Caffeine Blues_ Wake Up to the Hidden Dangers of America's #1 Drug ( PDFDrive )

by Неизвестный

  S. Tas, R. Lauwerys, and D. Lison, “Occupational Hazards for the Male

  Reproductive System,” Critical Reviews in Toxicology, May 1996;26(3):261–307. (back to text)

  222

  M. Cetinkaya, J. von Duszeln, W. Thiemann et al., “Organochlorine Pesticide Residues in Raw and Roasted Coffee and Their Degradation during the Roasting Process,” Zeitschrift fur Lebensmittel Untersuchung und Forschung, July 1984;179(1):5–8. (back to text)

  223

  L. Friedman, M. A. Weinberger, T. M. Farber et al., “Testicular Atrophy and Impaired Spermatogenesis in Rats Fed High Levels of the Methylxanthines Caffeine, Theobromine, or Theophylline,” Journal of Environmental Pathology and Toxicology, January 1979:2(3) :687–706. (back to text) 224

  A. R. Ezzat and Z. M. el-Gohary, “Hormonal and Histological Effects of Chronic Caffeine Administration on the Pituitary-gonadal and Pituitaryadrenocortical Axes in Male Rabbits,” Functional and Developmental Morphology, 1994;4(1):45–50. (back to text)

  225

  G. Potashnik and A. Porath, “Dibromochloropropane (DBCP):A 17-year Reassessment of Testicular Function and Reproductive Performance,” Journal of Occupational and Environmental Medicine, November 1995;37(11):1287–92.

  (back to text)

  226

  Ibid. (back to text)

  227

  D. S. Weathersbee, R. L. Ax, and J. R. Lodge, “Caffeine-mediated Changes of Sex Ratio in Chinese Hamsters,” Journal ofReproduction and Fertility, 1975;43:141–43. (back to text)

  228

  L. Fenster, D. F. Katz, A. J. Wyrobek et al., “Effects of Psychological Stress on Human Semen Quality,” Journal of ‘Andrology, March 1997;18(2):194–202.

  (back to text)

  229

  M. Fukuda, K. Fukuda, T. Shimizu et al., “Kobe Earthquake and Reduced Sperm Motility,” Human Reproduction, June 1996;11(6):1244–46. (back to text) 230

  M. J. De Souza, J. C. Arce, L. S. Pescatello et al., “Gonadal Hormones and Semen Quality in Male Runners: A Volume Threshold Effect of Endurance Training,” International Journal of Sports Medicine, October 1994;15(7):383–91. (back to text)

  231

  H. Kentenich, H. Schmiady, E. Radke et al., “The Male IVF Patient—Psychosomatic Considerations,” Human Reproduction, June 1992;7 supplement

  1:13–18. (back to text)

  232

  P. T. Giblin, M. L. Poland, K. S. Moghissi et al., “Effects of Stress and Characteristic Adaptability on Semen Quality in Healthy Men,” Fertility and Sterility, January 1988;49(1):127–32. (back to text)

  233

  K. K. Harrison, V. J. Callan, and J. R. Hennessey, “Stress and Semen Quality in an In Vitro Fertilization Program,” Fertility and Sterility, October 1987;48(4):633–36. (back to text)

  234

  K. D. Israel et al., “Serum Uric Acid in Carbohydrate Sensitive Adults,”

  Annals of Nutrition and Metabolism, 1983;32:1078–81. (back to text) 235

  M. M. Callahan, R. S. Robertson, M. J. Arnaud et al., “Human Metabolism of [1-methyl-l4C] and [2-14C] Caffeine after Oral Administration,” Drug Metabolism and Disposition, July 1982;10(4):417–23. (back to text) 236

  D. M. Grant, B. K. Tang, M. E. Campbell et al., “Effect of Allopurinol on Caffeine Disposition in Man,” British Journal of Clinical Pharmacology, April 1986;21(4):454–58. (back to text)

  237

  N. R. Scott, D. Stambuk, J. Chakraborty et al., “Caffeine Clearance and Biotransformation in Patients with Chronic Liver Disease,” Clinical Science, April 1988;74(4):377–84. (back to text)

  238

  R. H. Davis, “Does Caffeine Ingestion Affect Intraocular Pressure?”

  Ophthalmology, November 1989;96(11):1680–81. (back to text) 239

  E. J. Higginbotham, H. A. Kilimanjaro, J. T Wilensky et al., “The Effect of Caffeine on Intraocular Pressure in Glaucoma Patients,” Ophthalmology, May 1989;96(5):624–26. (back to text)

  240

  B. Hinzpeter and M. Diestelhorst, “1, 3, 7-trimethylxanthine: Effects on Orcadian Aqueous Humor Dynamics in Probands,” Ophthalmology, December 1992; 89(6):465–67. (back to text)

  241

  G. Duncan, R. A. Riach, M. R. Williams et al., “Calcium Mobilisation Modulates Growth of Lens Cells,” Cell Calcium, January 1996;19(1):83–89.

  (back to text)

  242

  K. Lofti and J. E. Grunwald, “The Effect of Caffeine on the Human Macular Circulation,” Investigative Ophthalmology and Visual Science, November 1991; 32(12):3028–32. (back to text)

  243

  Guide to Macular Degeneration,

  http://www.eyecare.org/consumer/disease/md.html (back to text) 244

  J. Evans and R. Wormald, “Is the Incidence of Registrable Age-related Macular Degeneration Increasing?” British Journal of Ophthalmology, January 1996;80(1):9–14. (back to text)

  Chapter 6

  1

  M. J. Arnaud, “Metabolism of Caffeine and Other Components of Coffee,” in S. Garattini (ed.), Caffeine, Coffee & Health, (New York: Raven Press, 1993), pp. 43–95. (back to text)

  2

  D. W. Yesair, “Human Disposition and Some Biochemical Aspects of Methylxanthines,” in G. A. Spiller, The Methylxanthine Beverages and Foods: Chemistry, Consumption and Health Effects (New York: Liss, 1984). (back to text)

  3

  L. Linde, “Mental Effects of Caffeine in Fatigued and Non-fatigued Female and Male Subjects,” Ergonomics, May 1995;38(5):864–85. (back to text) 4

  J. Ferri, “Under Pressure,” Tampa Tribune-Times, April 27, 1997, 1. (back to text)

  5

  T. E. Seeman, B. S. McEwen, B. H. Singer et al., “Increase in Urinary Cortisol Excretion and Memory Declines: MacArthur Studies of Successful Aging,”

  Journal of Clinical Endocrinology and Metabolism, 1997;82:2458–65. (back to text)

  6

  J. Ferri, “Under Pressure.” (back to text)

  7

  A. Gramenzi and A. Gentile et al., “Association between Certain Foods and Risk of Acute Myocardial Infarction in Women,” British Medical Journal, March 24, 1990;300(6727):771–73. (back to text)

  8

  R. B. Williams, J. C. Barefoot, J. A. Blumenthal et al., “Psychosocial Correlates of Job Strain in a Sample of Working Women,” Archives of General Psychiatry, June 1997;54(6):543–48. (back to text)

  9

  M. B. Schenker, M. Eaton, R. Green et al., “Self-reported Stress and Reproductive Health of Female Lawyers,” Journal of Occupational and Environmental Medicine, June 1997;39(6):556–68. (back to text)

  10

  M. E. Tucker, “Despite H. pylori, Stress Still a Factor in Ulcers,” Family Practice News, 1994;24(12):17. (back to text)

  11

  E. A. Bergman, L. K. Massey, K. J. Wise et al., “Effects of Dietary Caffeine on Renal Handling of Minerals in Adult Women,” Life Sciences, 1990;47(6):557–64. (back to text)

  12

  P. T. Packard and R. R. Recker, “CafFeine Does not Affect the Rate of Gain in Spine Bone in Young Women,” Osteoporosis International, 1996;6(2):149–52. (back to text)

  13

  D. C. Bauet, W. S. Browner, J. A. Cauley et al., “Factors Associated with Appendicular Bone Mass in Older Women: The Study of Osteoporotic Fractures Research Group,” Annals of ‘Internal Medicine, May 1, 1993;118(9):657–65.

  (back to text)

  14

  R. P. Heaney and R. R. Recker, “Effects of Nitrogen, Phosphorus, and Caffeine on Calcium Balance in Women,” Journal of Laboratory and Clinical Medicine, January 1982;99(1):46–55. (back to text)

  15

  C. Krahe, R. Friedman, J. L. Gross, “Risk Factors for Decreased Bone Density in Premenopausal Women,” Brazilian Journal of Medical and Biological Research, September 1997;30(9):106l–66. (back to text)

  16

  S. S. Harris and B. Dawson-Hughes, “Caffeine and Bone Loss in Healthy Postmenopausal Women,” American Journal of Clinical Nutrition, October 1994;60(4)
:573–78. (back to text)

  17

  L. K. Massey, E. A. Bergman, K. J. Wise et al., “Interactions between Dietary Caffeine and Calcium on Calcium and Bone Metabolism in Older Women,”

  Journal of the American College of Nutrition, December 1994;13(6):592–96.

  (back to text)

  18

  D. P. Kiel, D. T. Felson, M. T. Hannan et al., “Caffeine and the Risk of Hip Fracture: The Framingham Study,” American Journal of Epidemiology, October 1990;132(4):675–84. (back to text)

  19

  M. Hernandez-Avila, G. A. Colditz, M. J. Stampfei et al., “Caffeine, Moderate Alcohol Intake, and Risk of Fractures of the Hip and Forearm in Middle-aged Women,” American Journal of Clinical Nutrition, July 1991;54(1):157–63.

  (back to text)

  20

  D. Michelson, C. Stratakis, L. Hill et al., “Bone Mineral Density in Women

  with Depression,” New England Journal of Medicine, 1996;335:1176–81. (back to text)

  21

  J. E. White, “Osteoporosis: Strategies for Prevention,” Nurse Practitioner, September 1986;11(9):36–46. (back to text)

  22

  C L. Deal, “Osteoporosis, Prevention, Diagnosis, and Management,”

  American Journal of Medicine, January 27, 1997;102(1A):35S–39S. (back to text)

  23

  J. J. Anderson, P. Rondano, and A. Holmes, “Roles of Diet and Physical Activity in the Prevention of Osteoporosis,” Scandinavian Journal of Rheumatology, 1996,103:65–74. (back to text)

  24

  M. P. Faine, “Dietary Factors Related to Preservation of Oral and Skeletal Bone Mass in Women,” Journal of Prosthetic Dentistry, January 1995;73(1):65–72. (back to text)

  25

  V. W. Bunker, “The Role of Nutrition in Osteoporosis,” British Journal ofBiomedical Science, September 1994;51(3):228–40. (back to text) 26

  W. G. Thompson, “Coffee: Brew or Bane?” American Journal of the Medical Sciences, July 1994;308(1):49–57. (back to text)

  27

  T. Gillespy, 3d, and M. P. Gillespy, “Osteoporosis,” Radiology Clinics of North America, January 1991;29(1):77–84. (back to text) 28

  T. A. Morck, S. R. Lynch, and J. D. Cook, “Inhibition of Food Iron Absorption by Coffee,” American Journal of Clinical Nutrition, 1983;37(3):416–20. (back to text)

  29

  L. Hallberg, “Iron,” in Present Knowledge in Nutrition, 5th ed. (Washington D.C.: The Nutritional Foundation, 1984), pp. 459–78. Also E. M. Haymes, “Nutritional Concerns: Need for Iron,” Medicine and Science in Sports and Exercise, 1987; supplement 19:S197–S200. (back to text) 30

  G. B. Gabrielli and G. De Sandre, “ExcessiveTea Consumption Can Inhibit the Efficacy of Oral Iron Treatment in Irondeficiency Anemia,” Haematologica, November-December 1995;80(6):518–20. (back to text)

  31

  J. D. Cook, C. A. Finch, and N. J. Smith, “Evaluation of the Iron Status of a Population,” Blood, 1976;48:449–55. (back to text)

  32

  T. H. Bothwell, R. W. Charlton et al., Iron Metabolism in Man (Oxford,

  England: Blackwell Scientific Publications, 1979). (back to text) 33

  I. G. Ances, J. Granados, and M. Baltazar, “Serum Ferritin as an Early Determinant of Decreased Iron Stores in Pregnant Women,” Southern Medical Journal, May 1979;72(5):591–92. (back to text)

  34

  E: Kaneshige, “Serum Ferritin as an Assessment of Iron Stores and Other Hematologic Parameters during Pregnancy,” Obstetrics and Gynecology, February 1981;57(2):238–42. (back to text)

  35

  J. Buolakka, “Serum Ferritin in the Evaluation of Iron Status in Young Healthy Women,” Acta Obstetrica et Gynecologica Scandinavica, 1980; supplement 95:35–41. (back to text)

  36

  G. H. Guyatt, C. Patterson, M. Ali et al., “Diagnosis of Irondeficiency Anemia in the Elderly,” American Journal of Medicine, March 1990;88(3):205–09. (back to text)

  37

  G. H. Guyatt, A. D. Oxman, M. Ali et al., “Laboratory Diagnosis of Irondeficiency Anemia: An Overview,” Journal of General Internal Medicine, March–April 1992;7(2):145–53. (back to text)

  38

  J. Puolakka, O. Janne, A. Pakarinen et al., “Serum Ferritin in the Diagnosis of Anemia during Pregnancy,” Acta Obstetrica et Gynecologica Scandinavica, 1980; supplement 95:57–63. (back to text)

  39

  S. Kiechl, J. Willeit, G. Egger et al., “Body Iron Stores and the Risk of Carotid Atherosclerosis: Prospective Results from the Bruneck Study,”

  Circulation, November 18, 1997;96(10):3300–07. (back to text) 40

  A. B. Bruner, “Randomized Study of Cognitive Effects of Iron Supplementation in Non-anemic Irondeficient Adolescent Girls,” Lancet, 1996;348 (October 12), 992–96. (back to text)

  41

  A. M. Rossignol, “Caffeinecontaining Beverages and Premenstrual Syndrome in Young Women,” American Journal of Public Health, November 1985;75(11):1335–37. (back to text)

  42

  A. M. Rossignol and H. Bonnlander, “Caffeinecontaining Beverages, Total Fluid Consumption, and Premenstrual Syndrome,” American Journal of Public Health, September 1990;80(9):1106–10. (back to text)

  43

  A. M. Rossignol, H. Bonnlander, L. Song et al., “Do Women with Premenstrual Symptoms Self-medicate with Caffeine?” Epidemiology,

  November 1991;2(6):403–08. (back to text)

  44

  J. F. Mortola, L. Girton, and S. S. Yen, “Depressive Episodes in Premenstrual Syndrome,” American Journal of Obstetrics and Gynecology, December 1989;161(pt 1): 1682–87. (back to text)

  45

  A. M. Rossignol, J. Y. Zhang, Y. Z. Chen et al., “Tea and Premenstrual Syndrome in the People’s Republic of China,” American Journal of Public Health, January 1989;79(1):67–69. (back to text)

  46

  S. London, W. Willett, C. Longcope et al., “Alcohol and Other Dietary Factors in Relation to Serum Hormone Concentrations in Women at Climacteric,” American Journal of Clinical Nutrition, January 1991;53(1):166–71. (back to text)

  47

  R. L. Ferrini and E. Barrett-Connor, “Caffeine Intake and Endogenous Sex Steroid Levels in Postmenopausal Women: The Rancho Bernardo Study,”

  American Journal of Epidemiology, October 1, 1996;144(7):642–44. (back to text)

  48

  G. Del Rio, R. Menozzi, G. Zizzo et al., “Increased Cardiovascular Response to Caffeine in Perimenopausal Women Before and During Estrogen Therapy,”

  European Journal of Endocrinology, November 1996;135(5)598–603. (back to text)

  49

  M. A. Lucerno and W. W. McCloskey, “Alternatives to Estrogen for the Treatment of Hot Flashes,” Annals ofPharmacotherapy, July 1997;31(7–8):915–17. (back to text)

  50

  G. L. Clementz and J. W. Dailey, “Psychotropic Effects of Caffeine,”

  American Family Physician, May 1988;37(5):167–72. (back to text) 51

  A. Breier, D. S. Charney, and G. R. Heninger, “Agoraphobia with Panic Attacks: Development, Diagnostic Stability, and Course of Illness,” Archives of General Psychiatry, November 1986;43(11):1029–36. (back to text) 52

  F. W. Foote and F. W. Stewart, “Comparative Studies of Cancerous versus Non-cancerous Breasts,” Annals of Surgery, 1945;121:197–222. (back to text) 53

  P. G. Brooks, S. Gart, A. J. Heldfond et al., “Measuring the Effect of Caffeine Restriction on Fibrocystic Breast Disease: The Role of Graphic Stress Telethermometry as an Objective Monitor of Disease,” Journal of Reproductive Medicine, June 1981;26(6):279–82. (back to text)

  54

  M. C. Hindi-Alexander, M. A. Zielezny, N. Montes et al., “Theophylline and Fibrocystic Breast Disease,” Journal of Allergy and Clinical Immunology, June 1985;75(6):709–15. (back to text)

  55

  J. P. Minton and H. Abou-Issa, “Nonendocrine Theories of the Etiology of Benign Breast Disease,” World Journal of Surgery, November 1989;13
(6):680–84. (back to text)

  56

  J. P. Minton, M. K. Foecking et al., “Response of Fibrocystic Disease to Caffeine Withdrawal and Correlation of Cystic Nudeotides with Breast Disease,”

  American Journal of Obstetrics and Gynecology, 1979;135:157–58. (back to text)

  57

  L. C. Russell, “Caffeine Restriction as Initial Treatment for Breast Pain,”

  February 1989;14(2):36–37. (back to text)

  58

  B. Bullough, M. Hindi-Alexander, and S. Fetouh, “Methylxanthines and Fibrocystic Breast Disease: A Study of Correlations,” Nurse Practitioner, March 1990;15(3):36–38. (back to text)

  59

  P. Modica, “The Coffee Craze and Your Health,” Medical Tribune News Service, June 25, 1997. (back to text)

  60

  S. J. London, J. L. Connolly, S. J. Schnitt et al., “A Prospective Study of Benign Breast Disease and the Risk of Breast Cancer,” Journal of the American Medical Association, 1992;267(7):941–44. (back to text) 61